Trials / Completed
CompletedNCT00775892
SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair
A Multi-Center Open Label Study to Evaluate the SeriACL™ Device (Gen IB) for Primary Anterior Cruciate Ligament Repair
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Serica Technologies, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center single-arm clinical trial is being conducted to evaluate SeriACL device safety and performance during total anterior cruciate ligament (ACL) reconstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SeriACL Device ACL Reconstruction | Long-term Bioresorbable ACL Scaffold |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-05-01
- First posted
- 2008-10-20
- Last updated
- 2011-08-09
Locations
6 sites across 3 countries: Austria, Belgium, Germany
Source: ClinicalTrials.gov record NCT00775892. Inclusion in this directory is not an endorsement.